Pharmacokinetic Interaction Between Maraviroc And Fosamprenavir/Ritonavir In Healthy Subjects
Status:
Terminated
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
This is will be an open-label, fixed-sequence, multiple dose crossover study in 2 cohorts of
14 healthy male and/or female subjects, to estimate the effect of maraviroc on the
pharmacokinetics of amprenavir and ritonavir and fosamprenavir/ritonavir on the
pharmacokinetics of maraviroc.